Plasma renin levels are associated with cardiac function in primary adrenal insufficiency

Background Despite adequate glucocorticoid (GC) and mineralocorticoid (MC) replacement therapy, primary adrenal insufficiency (AI) is associated with an increased mortality, mainly due to cardiovascular disease. The role of MC replacement is not known. Therefore, we assessed whether renin concentrat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Endocrine 2019-08, Vol.65 (2), p.399-407
Hauptverfasser: Wolf, Peter, Beiglböck, Hannes, Fellinger, Paul, Pfleger, Lorenz, Aschauer, Stefan, Gessl, Alois, Marculescu, Rodrig, Trattnig, Siegfried, Kautzky-Willer, Alexandra, Luger, Anton, Winhofer, Yvonne, Krššák, Martin, Krebs, Michael
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 407
container_issue 2
container_start_page 399
container_title Endocrine
container_volume 65
creator Wolf, Peter
Beiglböck, Hannes
Fellinger, Paul
Pfleger, Lorenz
Aschauer, Stefan
Gessl, Alois
Marculescu, Rodrig
Trattnig, Siegfried
Kautzky-Willer, Alexandra
Luger, Anton
Winhofer, Yvonne
Krššák, Martin
Krebs, Michael
description Background Despite adequate glucocorticoid (GC) and mineralocorticoid (MC) replacement therapy, primary adrenal insufficiency (AI) is associated with an increased mortality, mainly due to cardiovascular disease. The role of MC replacement is not known. Therefore, we assessed whether renin concentrations during routine GC and MC substitution therapy are associated with heart function and morphology. Methods Thirty two patients with primary AI were included in a cross-sectional case–control study. In total, 17 patients and 34 healthy controls (age: 48 ± 12 vs. 46 ± 18 years; BMI: 23 ± 3 vs. 24 ± 3 kg/m 2 ) underwent magnetic resonance spectroscopy and imaging measurements to assess cardiac function, morphology, ectopic lipids, and visceral/subcutaneous fat mass. Patients were divided according to their actual plasma renin concentration at the study visit (Actual-Renin low vs. Actual-Renin high ) and their median plasma renin concentration of previous visits (Median-Renin low vs. Median-Renin high ). Results Ejection fraction was higher (67 ± 5 vs. 55 ± 3%; p  = 0.001) and left ventricular mass was lower (60 ± 9 vs. 73 ± 10 g/m 2 ; p  = 0.025) in Actual-Renin high . Median-Renin high was associated with lower cardiac mass (64 ± 9 vs. 76 ± 11 g/m 2 ; p  = 0.029). Blood pressure, glucose, and lipid metabolism, as well as ectopic lipid content, pericardial fat mass, and visceral/subcutaneous fat were not different between the groups. Compared with controls, ejection fraction was significantly lower in patients with AI (56 ± 4 vs. 63 ± 8%; p  = 0.019). No differences were found in patients with ≤20 mg compared with >20 mg of hydrocortisone per day. Conclusions Higher renin concentrations are associated with more favorable cardiac function and morphology in patients with primary AI.
doi_str_mv 10.1007/s12020-019-01974-1
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6656897</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2264209323</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3891-4ca5403728df66e991608116d0975058933bd904bc9da721b2e5ff8180aa01033</originalsourceid><addsrcrecordid>eNp9kT1PHDEQhq0oUSCEP0CBLKWh2WRsr7-aSBGCEAkpFCCRyprzesFoz0vsXRD_Hh93QJIiheWPeeadGb-E7DH4zAD0l8I4cGiA2dXSbcPekG0m5eoK8LaehZQNgLncIh9KuQHgnCv9nmwJxrRuebtNfp0NWJZIc0gx0SHchaFQzIFiKaOPOIWO3sfpmnrMXURP-zn5KY6JVvw2xyXmB4pdTcehPpW576OPIfmHj-Rdj0MJu5t9h1wcH50fnjSnP7__OPx22nhhLGtaj7IFobnpeqWCtUyBYUx1YLUEaawQi85Cu_C2Q83ZggfZ94YZQKxjCrFDvq51b-fFMnQ-pCnj4Da9uRGj-zuS4rW7Gu-cUlIZq6vAwUYgj7_nUCa3jMWHYcAUxrm4-mctByv4qtanf9Cbcc519CdKCG0UqErxNeXzWEoO_UszDNzKObd2zlXX3JNzjtWk_T_HeEl5tqoCYg2UGkpXIb_W_o_sIwxzo-g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2263378606</pqid></control><display><type>article</type><title>Plasma renin levels are associated with cardiac function in primary adrenal insufficiency</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Wolf, Peter ; Beiglböck, Hannes ; Fellinger, Paul ; Pfleger, Lorenz ; Aschauer, Stefan ; Gessl, Alois ; Marculescu, Rodrig ; Trattnig, Siegfried ; Kautzky-Willer, Alexandra ; Luger, Anton ; Winhofer, Yvonne ; Krššák, Martin ; Krebs, Michael</creator><creatorcontrib>Wolf, Peter ; Beiglböck, Hannes ; Fellinger, Paul ; Pfleger, Lorenz ; Aschauer, Stefan ; Gessl, Alois ; Marculescu, Rodrig ; Trattnig, Siegfried ; Kautzky-Willer, Alexandra ; Luger, Anton ; Winhofer, Yvonne ; Krššák, Martin ; Krebs, Michael</creatorcontrib><description>Background Despite adequate glucocorticoid (GC) and mineralocorticoid (MC) replacement therapy, primary adrenal insufficiency (AI) is associated with an increased mortality, mainly due to cardiovascular disease. The role of MC replacement is not known. Therefore, we assessed whether renin concentrations during routine GC and MC substitution therapy are associated with heart function and morphology. Methods Thirty two patients with primary AI were included in a cross-sectional case–control study. In total, 17 patients and 34 healthy controls (age: 48 ± 12 vs. 46 ± 18 years; BMI: 23 ± 3 vs. 24 ± 3 kg/m 2 ) underwent magnetic resonance spectroscopy and imaging measurements to assess cardiac function, morphology, ectopic lipids, and visceral/subcutaneous fat mass. Patients were divided according to their actual plasma renin concentration at the study visit (Actual-Renin low vs. Actual-Renin high ) and their median plasma renin concentration of previous visits (Median-Renin low vs. Median-Renin high ). Results Ejection fraction was higher (67 ± 5 vs. 55 ± 3%; p  = 0.001) and left ventricular mass was lower (60 ± 9 vs. 73 ± 10 g/m 2 ; p  = 0.025) in Actual-Renin high . Median-Renin high was associated with lower cardiac mass (64 ± 9 vs. 76 ± 11 g/m 2 ; p  = 0.029). Blood pressure, glucose, and lipid metabolism, as well as ectopic lipid content, pericardial fat mass, and visceral/subcutaneous fat were not different between the groups. Compared with controls, ejection fraction was significantly lower in patients with AI (56 ± 4 vs. 63 ± 8%; p  = 0.019). No differences were found in patients with ≤20 mg compared with &gt;20 mg of hydrocortisone per day. Conclusions Higher renin concentrations are associated with more favorable cardiac function and morphology in patients with primary AI.</description><identifier>ISSN: 1355-008X</identifier><identifier>EISSN: 1559-0100</identifier><identifier>DOI: 10.1007/s12020-019-01974-1</identifier><identifier>PMID: 31177424</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Addison Disease - blood ; Addison Disease - diagnostic imaging ; Addison Disease - drug therapy ; Addison Disease - physiopathology ; Adrenal glands ; Adult ; Aged ; Anti-Inflammatory Agents - administration &amp; dosage ; Blood pressure ; Body fat ; Cardiac function ; Cardiovascular diseases ; Case-Control Studies ; Cross-Sectional Studies ; Diabetes ; Endocrinology ; Female ; Glucocorticoids ; Glucose metabolism ; Heart ; Heart - diagnostic imaging ; Heart - physiopathology ; Hormone Replacement Therapy ; Humanities and Social Sciences ; Humans ; Hydrocortisone ; Hydrocortisone - administration &amp; dosage ; Internal Medicine ; Lipid metabolism ; Magnetic resonance imaging ; Magnetic Resonance Spectroscopy ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Morphology ; multidisciplinary ; Original ; Original Article ; Pilot Projects ; Renin ; Renin - blood ; Science ; Stroke Volume ; Ventricle</subject><ispartof>Endocrine, 2019-08, Vol.65 (2), p.399-407</ispartof><rights>The Author(s) 2019</rights><rights>Copyright Springer Nature B.V. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3891-4ca5403728df66e991608116d0975058933bd904bc9da721b2e5ff8180aa01033</citedby><cites>FETCH-LOGICAL-c3891-4ca5403728df66e991608116d0975058933bd904bc9da721b2e5ff8180aa01033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12020-019-01974-1$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12020-019-01974-1$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31177424$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wolf, Peter</creatorcontrib><creatorcontrib>Beiglböck, Hannes</creatorcontrib><creatorcontrib>Fellinger, Paul</creatorcontrib><creatorcontrib>Pfleger, Lorenz</creatorcontrib><creatorcontrib>Aschauer, Stefan</creatorcontrib><creatorcontrib>Gessl, Alois</creatorcontrib><creatorcontrib>Marculescu, Rodrig</creatorcontrib><creatorcontrib>Trattnig, Siegfried</creatorcontrib><creatorcontrib>Kautzky-Willer, Alexandra</creatorcontrib><creatorcontrib>Luger, Anton</creatorcontrib><creatorcontrib>Winhofer, Yvonne</creatorcontrib><creatorcontrib>Krššák, Martin</creatorcontrib><creatorcontrib>Krebs, Michael</creatorcontrib><title>Plasma renin levels are associated with cardiac function in primary adrenal insufficiency</title><title>Endocrine</title><addtitle>Endocrine</addtitle><addtitle>Endocrine</addtitle><description>Background Despite adequate glucocorticoid (GC) and mineralocorticoid (MC) replacement therapy, primary adrenal insufficiency (AI) is associated with an increased mortality, mainly due to cardiovascular disease. The role of MC replacement is not known. Therefore, we assessed whether renin concentrations during routine GC and MC substitution therapy are associated with heart function and morphology. Methods Thirty two patients with primary AI were included in a cross-sectional case–control study. In total, 17 patients and 34 healthy controls (age: 48 ± 12 vs. 46 ± 18 years; BMI: 23 ± 3 vs. 24 ± 3 kg/m 2 ) underwent magnetic resonance spectroscopy and imaging measurements to assess cardiac function, morphology, ectopic lipids, and visceral/subcutaneous fat mass. Patients were divided according to their actual plasma renin concentration at the study visit (Actual-Renin low vs. Actual-Renin high ) and their median plasma renin concentration of previous visits (Median-Renin low vs. Median-Renin high ). Results Ejection fraction was higher (67 ± 5 vs. 55 ± 3%; p  = 0.001) and left ventricular mass was lower (60 ± 9 vs. 73 ± 10 g/m 2 ; p  = 0.025) in Actual-Renin high . Median-Renin high was associated with lower cardiac mass (64 ± 9 vs. 76 ± 11 g/m 2 ; p  = 0.029). Blood pressure, glucose, and lipid metabolism, as well as ectopic lipid content, pericardial fat mass, and visceral/subcutaneous fat were not different between the groups. Compared with controls, ejection fraction was significantly lower in patients with AI (56 ± 4 vs. 63 ± 8%; p  = 0.019). No differences were found in patients with ≤20 mg compared with &gt;20 mg of hydrocortisone per day. Conclusions Higher renin concentrations are associated with more favorable cardiac function and morphology in patients with primary AI.</description><subject>Addison Disease - blood</subject><subject>Addison Disease - diagnostic imaging</subject><subject>Addison Disease - drug therapy</subject><subject>Addison Disease - physiopathology</subject><subject>Adrenal glands</subject><subject>Adult</subject><subject>Aged</subject><subject>Anti-Inflammatory Agents - administration &amp; dosage</subject><subject>Blood pressure</subject><subject>Body fat</subject><subject>Cardiac function</subject><subject>Cardiovascular diseases</subject><subject>Case-Control Studies</subject><subject>Cross-Sectional Studies</subject><subject>Diabetes</subject><subject>Endocrinology</subject><subject>Female</subject><subject>Glucocorticoids</subject><subject>Glucose metabolism</subject><subject>Heart</subject><subject>Heart - diagnostic imaging</subject><subject>Heart - physiopathology</subject><subject>Hormone Replacement Therapy</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Hydrocortisone</subject><subject>Hydrocortisone - administration &amp; dosage</subject><subject>Internal Medicine</subject><subject>Lipid metabolism</subject><subject>Magnetic resonance imaging</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Morphology</subject><subject>multidisciplinary</subject><subject>Original</subject><subject>Original Article</subject><subject>Pilot Projects</subject><subject>Renin</subject><subject>Renin - blood</subject><subject>Science</subject><subject>Stroke Volume</subject><subject>Ventricle</subject><issn>1355-008X</issn><issn>1559-0100</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><recordid>eNp9kT1PHDEQhq0oUSCEP0CBLKWh2WRsr7-aSBGCEAkpFCCRyprzesFoz0vsXRD_Hh93QJIiheWPeeadGb-E7DH4zAD0l8I4cGiA2dXSbcPekG0m5eoK8LaehZQNgLncIh9KuQHgnCv9nmwJxrRuebtNfp0NWJZIc0gx0SHchaFQzIFiKaOPOIWO3sfpmnrMXURP-zn5KY6JVvw2xyXmB4pdTcehPpW576OPIfmHj-Rdj0MJu5t9h1wcH50fnjSnP7__OPx22nhhLGtaj7IFobnpeqWCtUyBYUx1YLUEaawQi85Cu_C2Q83ZggfZ94YZQKxjCrFDvq51b-fFMnQ-pCnj4Da9uRGj-zuS4rW7Gu-cUlIZq6vAwUYgj7_nUCa3jMWHYcAUxrm4-mctByv4qtanf9Cbcc519CdKCG0UqErxNeXzWEoO_UszDNzKObd2zlXX3JNzjtWk_T_HeEl5tqoCYg2UGkpXIb_W_o_sIwxzo-g</recordid><startdate>201908</startdate><enddate>201908</enddate><creator>Wolf, Peter</creator><creator>Beiglböck, Hannes</creator><creator>Fellinger, Paul</creator><creator>Pfleger, Lorenz</creator><creator>Aschauer, Stefan</creator><creator>Gessl, Alois</creator><creator>Marculescu, Rodrig</creator><creator>Trattnig, Siegfried</creator><creator>Kautzky-Willer, Alexandra</creator><creator>Luger, Anton</creator><creator>Winhofer, Yvonne</creator><creator>Krššák, Martin</creator><creator>Krebs, Michael</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201908</creationdate><title>Plasma renin levels are associated with cardiac function in primary adrenal insufficiency</title><author>Wolf, Peter ; Beiglböck, Hannes ; Fellinger, Paul ; Pfleger, Lorenz ; Aschauer, Stefan ; Gessl, Alois ; Marculescu, Rodrig ; Trattnig, Siegfried ; Kautzky-Willer, Alexandra ; Luger, Anton ; Winhofer, Yvonne ; Krššák, Martin ; Krebs, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3891-4ca5403728df66e991608116d0975058933bd904bc9da721b2e5ff8180aa01033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Addison Disease - blood</topic><topic>Addison Disease - diagnostic imaging</topic><topic>Addison Disease - drug therapy</topic><topic>Addison Disease - physiopathology</topic><topic>Adrenal glands</topic><topic>Adult</topic><topic>Aged</topic><topic>Anti-Inflammatory Agents - administration &amp; dosage</topic><topic>Blood pressure</topic><topic>Body fat</topic><topic>Cardiac function</topic><topic>Cardiovascular diseases</topic><topic>Case-Control Studies</topic><topic>Cross-Sectional Studies</topic><topic>Diabetes</topic><topic>Endocrinology</topic><topic>Female</topic><topic>Glucocorticoids</topic><topic>Glucose metabolism</topic><topic>Heart</topic><topic>Heart - diagnostic imaging</topic><topic>Heart - physiopathology</topic><topic>Hormone Replacement Therapy</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Hydrocortisone</topic><topic>Hydrocortisone - administration &amp; dosage</topic><topic>Internal Medicine</topic><topic>Lipid metabolism</topic><topic>Magnetic resonance imaging</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Morphology</topic><topic>multidisciplinary</topic><topic>Original</topic><topic>Original Article</topic><topic>Pilot Projects</topic><topic>Renin</topic><topic>Renin - blood</topic><topic>Science</topic><topic>Stroke Volume</topic><topic>Ventricle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wolf, Peter</creatorcontrib><creatorcontrib>Beiglböck, Hannes</creatorcontrib><creatorcontrib>Fellinger, Paul</creatorcontrib><creatorcontrib>Pfleger, Lorenz</creatorcontrib><creatorcontrib>Aschauer, Stefan</creatorcontrib><creatorcontrib>Gessl, Alois</creatorcontrib><creatorcontrib>Marculescu, Rodrig</creatorcontrib><creatorcontrib>Trattnig, Siegfried</creatorcontrib><creatorcontrib>Kautzky-Willer, Alexandra</creatorcontrib><creatorcontrib>Luger, Anton</creatorcontrib><creatorcontrib>Winhofer, Yvonne</creatorcontrib><creatorcontrib>Krššák, Martin</creatorcontrib><creatorcontrib>Krebs, Michael</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Endocrine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wolf, Peter</au><au>Beiglböck, Hannes</au><au>Fellinger, Paul</au><au>Pfleger, Lorenz</au><au>Aschauer, Stefan</au><au>Gessl, Alois</au><au>Marculescu, Rodrig</au><au>Trattnig, Siegfried</au><au>Kautzky-Willer, Alexandra</au><au>Luger, Anton</au><au>Winhofer, Yvonne</au><au>Krššák, Martin</au><au>Krebs, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma renin levels are associated with cardiac function in primary adrenal insufficiency</atitle><jtitle>Endocrine</jtitle><stitle>Endocrine</stitle><addtitle>Endocrine</addtitle><date>2019-08</date><risdate>2019</risdate><volume>65</volume><issue>2</issue><spage>399</spage><epage>407</epage><pages>399-407</pages><issn>1355-008X</issn><eissn>1559-0100</eissn><abstract>Background Despite adequate glucocorticoid (GC) and mineralocorticoid (MC) replacement therapy, primary adrenal insufficiency (AI) is associated with an increased mortality, mainly due to cardiovascular disease. The role of MC replacement is not known. Therefore, we assessed whether renin concentrations during routine GC and MC substitution therapy are associated with heart function and morphology. Methods Thirty two patients with primary AI were included in a cross-sectional case–control study. In total, 17 patients and 34 healthy controls (age: 48 ± 12 vs. 46 ± 18 years; BMI: 23 ± 3 vs. 24 ± 3 kg/m 2 ) underwent magnetic resonance spectroscopy and imaging measurements to assess cardiac function, morphology, ectopic lipids, and visceral/subcutaneous fat mass. Patients were divided according to their actual plasma renin concentration at the study visit (Actual-Renin low vs. Actual-Renin high ) and their median plasma renin concentration of previous visits (Median-Renin low vs. Median-Renin high ). Results Ejection fraction was higher (67 ± 5 vs. 55 ± 3%; p  = 0.001) and left ventricular mass was lower (60 ± 9 vs. 73 ± 10 g/m 2 ; p  = 0.025) in Actual-Renin high . Median-Renin high was associated with lower cardiac mass (64 ± 9 vs. 76 ± 11 g/m 2 ; p  = 0.029). Blood pressure, glucose, and lipid metabolism, as well as ectopic lipid content, pericardial fat mass, and visceral/subcutaneous fat were not different between the groups. Compared with controls, ejection fraction was significantly lower in patients with AI (56 ± 4 vs. 63 ± 8%; p  = 0.019). No differences were found in patients with ≤20 mg compared with &gt;20 mg of hydrocortisone per day. Conclusions Higher renin concentrations are associated with more favorable cardiac function and morphology in patients with primary AI.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>31177424</pmid><doi>10.1007/s12020-019-01974-1</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1355-008X
ispartof Endocrine, 2019-08, Vol.65 (2), p.399-407
issn 1355-008X
1559-0100
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6656897
source MEDLINE; SpringerLink Journals
subjects Addison Disease - blood
Addison Disease - diagnostic imaging
Addison Disease - drug therapy
Addison Disease - physiopathology
Adrenal glands
Adult
Aged
Anti-Inflammatory Agents - administration & dosage
Blood pressure
Body fat
Cardiac function
Cardiovascular diseases
Case-Control Studies
Cross-Sectional Studies
Diabetes
Endocrinology
Female
Glucocorticoids
Glucose metabolism
Heart
Heart - diagnostic imaging
Heart - physiopathology
Hormone Replacement Therapy
Humanities and Social Sciences
Humans
Hydrocortisone
Hydrocortisone - administration & dosage
Internal Medicine
Lipid metabolism
Magnetic resonance imaging
Magnetic Resonance Spectroscopy
Male
Medicine
Medicine & Public Health
Middle Aged
Morphology
multidisciplinary
Original
Original Article
Pilot Projects
Renin
Renin - blood
Science
Stroke Volume
Ventricle
title Plasma renin levels are associated with cardiac function in primary adrenal insufficiency
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T10%3A49%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20renin%20levels%20are%20associated%20with%20cardiac%20function%20in%20primary%20adrenal%20insufficiency&rft.jtitle=Endocrine&rft.au=Wolf,%20Peter&rft.date=2019-08&rft.volume=65&rft.issue=2&rft.spage=399&rft.epage=407&rft.pages=399-407&rft.issn=1355-008X&rft.eissn=1559-0100&rft_id=info:doi/10.1007/s12020-019-01974-1&rft_dat=%3Cproquest_pubme%3E2264209323%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2263378606&rft_id=info:pmid/31177424&rfr_iscdi=true